Skip to main content
Fig. 1 | Trials

Fig. 1

From: Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: a randomized controlled trial

Fig. 1

Schedule of enrollment, interventions, and assessments in accordance with Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT). M metformin, D/M dapagliflozin/metformin, BMI body mass index, WC waist circumference, TC total cholesterol, TG triglycerides, HDL-c high density cholesterol, LDL-c low density cholesterol, IL-6 interleukin-6, IL-10 interleukin-10, AE adverse event, SE secondary event

Back to article page

Trials

ISSN: 1745-6215